COMMUNIQUÉS West-GlobeNewswire

OrthoPediatrics Corp. to Report Second Quarter 2018 Financial Results on August 8, 2018
25/07/2018
Conference Call to Discuss Results on August 9, 2018 at 8:00 a.m. ET WARSAW, Ind., July 25, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ:KIDS), an orthopedic company focused exclusively on [...]
Albireo Appoints Patrick Horn MD, PhD as Chief Medical Officer
25/07/2018
--- Pediatrician with extensive orphan drug development expertise --- --- Experience with multiple Phase 3 programs and FDA submissions --- BOSTON, July 25, 2018 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq:ALBO), a [...]
Rubius Therapeutics to Acquire Manufacturing Facility in Smithfield, Rhode Island to Produce Red Cell Therapeutics
25/07/2018
CAMBRIDGE, Mass., July 25, 2018 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq:RUBY), a biotechnology company pioneering the development of a new class of ready-to-use cellular therapies, today announced that it [...]
Nabriva Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
25/07/2018
DUBLIN, Ireland and KING OF PRUSSIA, Pa. and SAN DIEGO, July 25, 2018 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ:NBRV), a clinical stage biopharmaceutical company engaged in the research and development of [...]
Bespoke Extracts Supports Make a Difference Foundation’s Provision of Blanket Warming System for Patients in Treatment at Florida Cancer Specialists & Research Institute in West Palm Beach
25/07/2018
SUNNY ISLES, Fla., July 25, 2018 (GLOBE NEWSWIRE) -- Bespoke Extracts, Inc. (OTCQB:BSPK), producer of high quality, great tasting, hemp-derived CBD extract products, is pleased to announce its support of Make A [...]
Syntactx Announces Expansion of Regulatory Affairs Leadership Team
25/07/2018
Company Names Three Industry Veterans to Lead Regulatory Affairs Team: Marlene Barton, Vice President, Department Head; Chie Iwaishi, Senior Director; and Darlene Garner, Manager Appointments Reflect Company’s Enhanced [...]
Endocyte Announces Second Quarter 2018 Financial Results and Operational Update Call
25/07/2018
WEST LAFAYETTE, Ind., July 25, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced that the company will [...]
Sientra to Present at the Canaccord 38th Annual Growth Stock Conference
25/07/2018
SANTA BARBARA, Calif., July 25, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company, announced today that members of the management team are scheduled to present at the Canaccord 38 th [...]
Minerva Neurosciences Names Devin Smith Senior Vice President, General Counsel
25/07/2018
WALTHAM, Mass., July 25, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) [...]
INSYS Therapeutics to Report Second Quarter 2018 Results on Aug. 8
25/07/2018
PHOENIX, July 25, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ:INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced that [...]
Immune Design to Report Second Quarter 2018 Financial Results and Provide Corporate Update
25/07/2018
SEATTLE and SOUTH SAN FRANCISCO, Calif., July 25, 2018 (GLOBE NEWSWIRE) -- Immune Design (Nasdaq:IMDZ), an immunotherapy company focused on next-generation therapies in oncology, today announced that it will report [...]
Apixio Launches HCC Auditor, the First AI-Powered Risk Adjustment Auditing Solution
25/07/2018
50 percent of health plan coders claim that their organization reviews less than 10 percent of charts pulled for risk adjustment coding – putting organizations at financial and compliance risk SAN MATEO, Calif., July 25 [...]
HempAmericana Provides Progress Update on CBD Oil Operations
25/07/2018
NEW YORK, July 25, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE--HempAmericana, Inc. (OTC:HMPQ) (“HempAmericana” or the “Company”) is proud to update shareholders and the wider investment community on the Company’s strong [...]
RedHill Biopharma Initiates Co-Promotion of HIV/AIDS Anti-Diarrheal Drug Mytesi®
25/07/2018
Mytesi ® is an FDA-approved anti-diarrheal prescription drug indicated for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on anti-retroviral therapy (ART) Mytesi ® is the fourth product being [...]
Trogarzo(TM) Included in Most Recent Treatment Guidelines Issued by International Antiviral Society
25/07/2018
MONTREAL, July 25, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX:TH) is pleased to announce that Trogarzo™ (ibalizumab-uiyk) injection is now included in the most recent version of the [...]
L’International Antiviral Society ajoute Trogarzo(MC) à ses directives de traitement
25/07/2018
MONTRÉAL, 25 juill. 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX:TH) est heureuse d’annoncer que Trogarzo MC (ibalizumab-uiyk) injection a été ajouté à la plus récente version des directives [...]
Changes to the Management Board of AS Olainfarm
25/07/2018
Changes to the Management Board of AS Olainfarm AS Olainfarm hereby informs about the following decisions taken by its Supervisory Council on July 24, 2018: Remove Salvis Lapins from position of Board member of AS [...]
Sonoma Pharmaceuticals Announces First Quarter FY 2019 Financial Results and Conference Call
25/07/2018
PETALUMA, Calif., July 25, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA) today announced that financial results for its fiscal year 2019 first quarter, ended June 30, 2018, will be released after [...]
IMV Inc. to Present at the Canaccord Genuity 38th Annual Growth Conference
25/07/2018
HALIFAX, Nova Scotia, July 25, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (Nasdaq:IMV) (TSX:IMV), a clinical stage immuno-oncology corporation, today announced that IMV Chief Executive Officer Frederic Ors will present a [...]

Pages